[1]
Luis Cavero-Roig, L. Cavero-Negre, A. Monés-Llivina, Àngels Ferrero-Rosanas, P. S. Ventura, and J. M. Siurana*, “The Cardiovascular Effects of Treatment with Atropine 0.01% Eyedrops to prevent the Progression of Childhood Myopia: Cardiovascular effects of treatment with atropine 0.01% in children”, J Cardiovasc Med Cardiol, vol. 11, no. 2, pp. 024–026, Jun. 2024.